Experience with administration of 15-deoxyspergualin in rejection in kidney transplant recipients.
Jiang
H
H
Department of Urology, Osaka University Hospital, Japan.
Takahara
S
S
Takano
Y
Y
Kokado
Y
Y
Kameoka
H
H
Moutabarrik
A
A
Ishibashi
M
M
Okuyama
A
A
Sonoda
T
T
D000328:Adult; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000097:blood / Q000627:therapeutic use; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy*; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D012263:Ribonucleosides / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
D006146:Guanidines; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D016572:Cyclosporine; D003404:Creatinine; C037258:gusperimus; D008775:Methylprednisolone